UY28622A1 - QUINOLONA ANTIBACTERIAL AGENTS - Google Patents

QUINOLONA ANTIBACTERIAL AGENTS

Info

Publication number
UY28622A1
UY28622A1 UY28622A UY28622A UY28622A1 UY 28622 A1 UY28622 A1 UY 28622A1 UY 28622 A UY28622 A UY 28622A UY 28622 A UY28622 A UY 28622A UY 28622 A1 UY28622 A1 UY 28622A1
Authority
UY
Uruguay
Prior art keywords
antibacterial agents
iii
formula
quinolona
compounds
Prior art date
Application number
UY28622A
Other languages
Spanish (es)
Inventor
Denton Wade Hoyer
Chris Limberakis
Clarke Bentley Taylor
Edmund Lee Ellsworth
Sean Timothy Murphy
Mark Ryan Rauckhorst
Jeremy Tyson Starr
Kim Marie Hutchings
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of UY28622A1 publication Critical patent/UY28622A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen compuestos de fórmula I, II, III, v, V y VI y procedimientos para su preparación. Tambie´n se describen procedimientos para fabricar compuestos biológicamente activos de fórmula I, II, III, IV, V y VI a´sí como composiciones farmacéuticamente aceptables que comprenden compuestos de fórmula I, II, III, IV, V y VI. Los compuestos de fórmula I, II, III, IV, V y VI, como se describen en este documento, pueden usarse en diversas aplicaciones incluyendo su uso como agentes antibacterianos.Compounds of formula I, II, III, v, V and VI and processes for their preparation are described. Methods for manufacturing biologically active compounds of formula I, II, III, IV, V and VI therein are also described as pharmaceutically acceptable compositions comprising compounds of formula I, II, III, IV, V and VI. The compounds of formula I, II, III, IV, V and VI, as described herein, can be used in various applications including their use as antibacterial agents.

UY28622A 2003-11-18 2004-11-17 QUINOLONA ANTIBACTERIAL AGENTS UY28622A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52307103P 2003-11-18 2003-11-18
US60549604P 2004-08-31 2004-08-31

Publications (1)

Publication Number Publication Date
UY28622A1 true UY28622A1 (en) 2005-06-30

Family

ID=34623167

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28622A UY28622A1 (en) 2003-11-18 2004-11-17 QUINOLONA ANTIBACTERIAL AGENTS

Country Status (6)

Country Link
AR (1) AR046638A1 (en)
NL (1) NL1027545C2 (en)
PE (1) PE20050582A1 (en)
TW (1) TW200524930A (en)
UY (1) UY28622A1 (en)
WO (1) WO2005049602A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100410249C (en) 2003-09-10 2008-08-13 杏林制药株式会社 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) Q uinolonecarboxylic acid derivative
WO2007019346A1 (en) 2005-08-04 2007-02-15 Sirtris Pharmaceuticals, Inc. Benzothiazoles and thiazolopyridines as sirtuin modulators
DE102006005861A1 (en) * 2006-02-09 2007-08-23 Aicuris Gmbh & Co. Kg Substituted quinolones III
MY162052A (en) * 2007-01-05 2017-05-31 Daiichi Sankyo Co Ltd Fused substitute aminopyrrolidine derivative
CN101622240B (en) * 2007-01-05 2014-07-23 第一三共株式会社 Fused substituted aminopyrrolidine derivative
CA2688008A1 (en) 2007-05-24 2008-11-27 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
DE102007036068A1 (en) 2007-08-01 2009-02-05 Wacker Chemie Ag Process for the preparation of alkylmethoxymethyltrimethylsilanylmethylamines
EP2295406B1 (en) 2008-05-30 2014-04-23 Takeda Pharmaceutical Company Limited Heterocyclic compound
BRPI1008661B8 (en) 2009-02-06 2021-05-25 Nippon Shinyaku Co Ltd aminopyrazine-derived compounds, their use and pharmaceutical composition
AR091858A1 (en) * 2012-07-25 2015-03-04 Sova Pharmaceuticals Inc CISTATIONIN-g-LIASA INHIBITORS (CSE)
JP6908536B2 (en) 2015-06-09 2021-07-28 バイエル・ファルマ・アクティエンゲゼルシャフト Positive allosteric modulator of muscarinic M2 receptor
WO2018011017A1 (en) 2016-07-11 2018-01-18 Bayer Pharma Aktiengesellschaft 7-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereof
JOP20190045A1 (en) 2016-09-14 2019-03-14 Bayer Ag 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof
EP3296298A1 (en) 2016-09-14 2018-03-21 Bayer Pharma Aktiengesellschaft 7-substituted 1-aryl-naphthyridin-3-carboxamides and their use
EP3519392A1 (en) 2016-09-29 2019-08-07 Bayer CropScience Aktiengesellschaft Novel 5-substituted imidazole derivatives

Also Published As

Publication number Publication date
NL1027545C2 (en) 2006-01-17
TW200524930A (en) 2005-08-01
AR046638A1 (en) 2005-12-14
NL1027545A1 (en) 2005-05-23
WO2005049602A1 (en) 2005-06-02
PE20050582A1 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
BRPI0507653A (en) imidazopyridine derivatives and imidazopyridine pharmaceutical formulation comprising the same and use
UY27760A1 (en) NEW DERIVATIVES OF PIRROLIDINIO.
UY28622A1 (en) QUINOLONA ANTIBACTERIAL AGENTS
UY28514A1 (en) NEW COMPOUNDS
CR8559A (en) PIRAZOLOPIRIMIDINAS
UY29795A1 (en) ADENINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
UY27571A1 (en) 2-TIO-3, 5-DICIAN-4-PHENYL-6-REPLACED AMINOPIRIDINS AND THEIR USE
DOP2002000433A (en) 2-TIO-3,5-DICIANO-4-FENIL-6-SUBSTITUTED AMINOPIRIDINS AND THEIR USE
AR048878A1 (en) TOPIC COMPOSITIONS OF METADONA AND METHODS FOR USE
ECSP034774A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
ECSP034773A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
UY29234A1 (en) ADAMANTAN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, BOTH PREPARATION PROCEDURES AND APPLICATIONS.
BRPI0212137A2 (en) dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
UY30327A1 (en) NEW COMPOUNDS II
UY28510A1 (en) CHEMICAL COMPOUNDS
UY29420A1 (en) DERIVATIVES OF 2-PIRIDONA, COMPOSITIONS THAT CONTAIN THEM, PREPARATION AND APPLICATION PROCESSES
CL2003002770A1 (en) COMPOUNDS DERIVED FROM PIRROL AND IMIDDAZOL; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM; PREPARATION PROCEDURE; AND ITS USE IN THE TREATMENT AND / OR PREVENTION OF DISEASES THAT ARE ASSOCIATED WITH THE MODULATION OF CANABINOID RECEPTORS
BR0107770A (en) 3-Phenoxy-1-phenyl acetylene derivatives and their use as herbicides
UY31071A1 (en) REPLACED HETEROCICLIC DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS
UY30544A1 (en) PIRROLO-PIPERIDINE COMPOUNDS AND PHARMACEUTICAL SALTS ACCEPTABLE OF THE SAME, MANUFACTURING PROCESSES, COMPOSITIONS AND APPLICATIONS
UY31334A1 (en) 3A, 4,5,6,7,7A-HEXAHIDRO-3H-BENZOIMIDAZOL AND DERIVAODS OF 3A, 4,5,6,, 7,7A-HEXAHIDRO-3-INDOL, ENANTIOMERS, DIASTEREOISOMERS, PHARMACEUTICALLY ACCEPTED SALTS, MIXTURES, COMPOSITIONS , PREPARATIONS AND APPLICATIONS OF THE SAME
UY30393A1 (en) SUBSTITUTED DERIVATIVES OF 1-PIPERIDIN-1-IL-1,3-DIHIDRO-2H-BENZIMIDAZOL-2-ONA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
UY28694A1 (en) NEW COMPOUNDS
UY29892A1 (en) NEW CHROMAN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
UY28536A1 (en) DERIVATIVES OF BENCIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATION AND USES OF THE SAME.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150525